Roger Newton

Esperion logo

Esperion Therapeutics Reports Financial Details, Corporate Update

Esperion Therapeutics Inc. (Nasdaq: ESPR), an early-stage pharmaceutical company developing a new class of cholesterol-fighting drugs, Monday provided financial figures and a corporate update.

WWJ Newsradio 950–08/12/2013

Esperion logo

Tim Mayleben Named President And CEO Of Esperion Therapeutics

Esperion Therapeutics, the leading developer of small molecule therapies for the treatment of cardiometabolic disorders, announced that Tim Mayleben has been named president and CEO of the company.

WWJ Newsradio 950–01/06/2013

Follow

Get every new post delivered to your Inbox.

Join 1,975 other followers